Bio Medica Laboratories Limited has made an Initial Public Offering comprising of a fresh issue and an offer for sale by Selling Shareholders, aggregating to ₹52.43 crore.
Legacy Law Offices advised and acted Bio Medica Laboratories, the selling shareholders Mr Mukesh Mehta and Mr Pradeep Mehta, as well as the Book Running Lead Manager Narnolia Financial Services Ltd, on this IPO.
The transaction was led by Pradyun Chakravarty (Partner) and Naman Anand (Counsel), with support from Associates Meghna Shukla and Pallash Pamnani.
Bio Medica Laboratories is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures a variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections.
Read our annual IPO Coverage
Law Firm for the Issuer and Bankers in 2024-25
IPO Report: Which firms dominated the ₹1,000+ crore segment?
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.